Literature DB >> 6609223

Behavior of vanadate and vanadyl ion in canine blood.

W R Harris, S B Friedman, D Silberman.   

Abstract

Radiolabeled vanadium as either vanadyl ion or vanadate ion was injected intravenously into adult beagle dogs, and blood samples were collected at various times up to 48 hr post injection. For each sample, the distribution of vanadium between the cells and the plasma was determined, and the plasma was analyzed by electrophoresis to identify specific vanadium-binding proteins. Initially, vanadyl ion left the bloodstream more rapidly than vanadate, but the rates equalized after about 5 hr. A significant fraction of the vanadium in blood was associated with the cellular component following injection of both forms of vanadium. About 77% of the plasma vanadium was eventually bound by the serum iron transport protein transferrin, regardless of the vanadium species initially injected. For both vanadyl and vanadate, about 30 hr were required to reach the maximum degree of transferrin binding.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609223     DOI: 10.1016/0162-0134(84)80015-x

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  5 in total

1.  X-ray-induced photo-chemistry and X-ray absorption spectroscopy of biological samples.

Authors:  Graham N George; Ingrid J Pickering; M Jake Pushie; Kurt Nienaber; Mark J Hackett; Isabella Ascone; Britt Hedman; Keith O Hodgson; Jade B Aitken; Aviva Levina; Christopher Glover; Peter A Lay
Journal:  J Synchrotron Radiat       Date:  2012-10-18       Impact factor: 2.616

2.  Peripheral erythrocyte levels, hemolysis and three vanadium compounds.

Authors:  G R Hogan
Journal:  Experientia       Date:  1990-05-15

3.  Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients.

Authors:  Gail R Willsky; Katherine Halvorsen; Michael E Godzala; Lai-Har Chi; Mathew J Most; Peter Kaszynski; Debbie C Crans; Allison B Goldfine; Paul J Kostyniak
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

4.  A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice.

Authors:  J K Jackson; W Min; T F Cruz; S Cindric; L Arsenault; D D Von Hoff; D Degan; W L Hunter; H M Burt
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical Review.

Authors:  Thomas Scior; Jose Antonio Guevara-Garcia; Quoc-Tuan Do; Philippe Bernard; Stefan Laufer
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.